Karen L. Laurie

792 Elizabeth Street
Melbourne, VIC 3000, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Epistasis facilitates the long-term antigenic evolution of the influenza B virus hemagglutinin.

Epistasis facilitates the long-term antigenic evolution of the influenza B virus hemagglutinin.

Journal: bioRxiv : the preprint server for biology

Published: August 01, 2026

Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B viruses.

Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B viruses.

Journal: Science translational medicine

Published: April 01, 2026

Using an RNA binding protein to detect mRNA on lipid nanoparticles.

Using an RNA binding protein to detect mRNA on lipid nanoparticles.

Journal: Scientific reports

Published: September 05, 2025

Utilisation of monoclonal antibodies in the single radial immunodiffusion assay to determine potency and stability for seasonal and pandemic influenza vaccines.

Utilisation of monoclonal antibodies in the single radial immunodiffusion assay to determine potency and stability for seasonal and pandemic influenza vaccines.

Journal: Frontiers in immunology

Published: August 31, 2025

Understanding the Implications of Delaying Seasonal Influenza Vaccine Recommendations: An Industry Perspective.

Understanding the Implications of Delaying Seasonal Influenza Vaccine Recommendations: An Industry Perspective.

Journal: Vaccines

Published: July 20, 2025

Correction: Rockman et al. Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness. Vaccines 2023, 11, 52.

Correction: Rockman et al. Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness. Vaccines 2023, 11, 52.

Journal: Vaccines

Published: November 10, 2023

An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines.

An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines.

Journal: Frontiers in immunology

Published: January 18, 2023

Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness.

Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness.

Journal: Vaccines

Published: December 02, 2022

Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation.

Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation.

Journal: Frontiers in immunology

Published: October 30, 2021

Influenza lineage extinction during the COVID-19 pandemic?

Influenza lineage extinction during the COVID-19 pandemic?

Journal: Nature reviews. Microbiology

Published: September 29, 2021

Enhanced isolation of influenza viruses in qualified cells improves the probability of well-matched vaccines.

Enhanced isolation of influenza viruses in qualified cells improves the probability of well-matched vaccines.

Journal: NPJ vaccines

Published: May 27, 2021

IL-17A is a common and critical driver of impaired lung function and immunopathology induced by influenza virus, rhinovirus and respiratory syncytial virus.

IL-17A is a common and critical driver of impaired lung function and immunopathology induced by influenza virus, rhinovirus and respiratory syncytial virus.

Journal: Respirology (Carlton, Vic.)

Published: April 07, 2021

Showing 1-12 of 57

Last Updated: 09/26/2026